Flossbach Von Storch’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-753
Closed -$215K 114
2024
Q1
$215K Buy
+753
New +$220K ﹤0.01% 115
2020
Q4
Sell
-12,760
Closed -$3.24M 93
2020
Q3
$3.24M Hold
12,760
0.02% 80
2020
Q2
$3.01M Sell
12,760
-2,680
-17% -$611K 0.02% 85
2020
Q1
$3.13M Buy
15,440
+10,950
+244% +$2.39M 0.02% 79
2019
Q4
$1.08M Sell
4,490
-44,600
-91% -$9.83M 0.01% 95
2019
Q3
$9.5M Buy
49,090
+500
+1% +$96K 0.08% 58
2019
Q2
$8.95M Buy
48,590
+340
+0.7% +$60.9K 0.08% 58
2019
Q1
$9.17M Buy
48,250
+3,200
+7% +$611K 0.08% 58
2018
Q4
$8.77M Sell
45,050
-758
-2% -$148K 0.08% 56
2018
Q3
$9.5M Sell
45,808
-19,700
-30% -$3.88M 0.09% 58
2018
Q2
$12.1M Buy
65,508
+5,400
+9% +$955K 0.12% 55
2018
Q1
$10.2M Sell
60,108
-71,292
-54% -$13.1M 0.11% 59
2017
Q4
$22.9M Sell
131,400
-212,870
-62% -$37.7M 0.22% 45
2017
Q3
$64.2M Sell
344,270
-972,250
-74% -$172M 0.67% 30
2017
Q2
$227M Buy
1,316,520
+99,030
+8% +$16.1M 2.58% 14
2017
Q1
$200M Sell
1,217,490
-175,412
-13% -$29.1M 3.06% 10
2016
Q4
$204M Buy
1,392,902
+179,750
+15% +$27.1M 3.3% 9
2016
Q3
$202M Sell
1,213,152
-50,190
-4% -$8.49M 3.37% 11
2016
Q2
$192M Buy
1,263,342
+83,610
+7% +$13M 3.3% 12
2016
Q1
$177M Buy
1,179,732
+296,850
+34% +$44.1M 2.82% 14
2015
Q4
$143M Sell
882,882
-374,520
-30% -$58.9M 2.44% 17
2015
Q3
$174M Buy
1,257,402
+172,732
+16% +$27.2M 3.03% 12
2015
Q2
$167M Buy
1,084,670
+146,670
+16% +$23.5M 3.22% 10
2015
Q1
$150M Buy
938,000
+786,450
+519% +$124M 3.39% 11
2014
Q4
$24.1M Sell
151,550
-604,111
-80% -$94.1M 0.57% 33
2014
Q3
$106M Sell
755,661
-2,589
-0.3% -$338K 2.3% 22
2014
Q2
$89.8M Buy
758,250
+251,250
+50% +$29.1M 2.15% 19
2014
Q1
$62.5M Buy
507,000
+100,110
+25% +$12.1M 1.66% 21
2013
Q4
$46.4M Buy
406,890
+12,500
+3% +$1.42M 1.32% 23
2013
Q3
$44.1M Sell
394,390
-214,510
-35% -$23.3M 1.36% 24
2013
Q2
$60.1M Buy
+608,900
New +$63.2M 1.82% 19

Other funds holding AMGN

Flossbach Von Storch's AMGN Position: Q2 2024 in Review

Flossbach Von Storch sold out of Amgen (AMGN) in Q2 2024, closing a stake of 753 shares — an estimated $215K sold.

Flossbach Von Storch first reported a position in AMGN in Q2 2013 and held it in 31 quarters. The position peaked at $227M in Q2 2017. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Flossbach Von Storch reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Flossbach Von Storch sold 753 Amgen shares in Q2 2024, an estimated $215K.
  • Flossbach Von Storch first reported a position in Amgen in Q2 2013 and held it in 31 quarters.
  • Flossbach Von Storch's Amgen position peaked at $227M in Q2 2017.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Flossbach Von Storch's 13F filing for Q2 2024, filed 2 Aug 2024.